SCHEMBL12331365

SCHEMBL12331365

COC(C[C@@H](C)[C@H]1C[C@H](O)[C@@]2(C)C3CC[C@H]4C(C)(C)C(O)CCC45CC35CCC12C)C(OC(=O)N(C)C)C(C)(C)O

nearest known ligand 0.45

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ HSD11B1 P28845 1/20 0.45
▸ HSD11B2 P80365 1/20 0.45
▸ PSEN1 P49768 16/20 0.43
▸ PSEN2 P49810 16/20 0.43
▸ APH1B Q8WW43 16/20 0.43
▸ NCSTN Q92542 16/20 0.43
▸ APH1A Q96BI3 16/20 0.43
▸ PSENEN Q9NZ42 16/20 0.43
▸ PTPN11 Q06124 1/20 0.42
▸ ACLY P53396 2/20 0.40
▸ ACACA Q13085 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12331672 0.91 PSEN1 (0.51) HSD11B1HSD11B2PSEN1PSEN2APH1B
SCHEMBL12233467 0.91 PSEN1 (0.51) HSD11B1HSD11B2PSEN1PSEN2APH1B
SCHEMBL14772373 0.91 PSEN1 (0.51) HSD11B1HSD11B2PSEN1PSEN2APH1B
SCHEMBL12234862 0.89 PSEN1 (0.46) HSD11B1HSD11B2PSEN1PSEN2APH1B
SCHEMBL12232930 0.88 PTPN11 (0.44) HSD11B1HSD11B2PSEN1PSEN2APH1B
SCHEMBL12233934 0.80 PSEN1 (0.56) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL12332258 0.80 PSEN1 (0.56) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL12233397 0.80 PTPN11 (0.48) HSD11B1HSD11B2PSEN1PSEN2APH1B
SCHEMBL12332213 0.80 PTPN11 (0.46) HSD11B1HSD11B2PSEN1PSEN2APH1B
SCHEMBL12331593 0.79 PSEN1 (0.56) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011109657-A1 COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS SATORI PHARMACEUTICALS, INC. (US) 2011-09-09 — — WO disclosed
Send feedback